From the LBT annual report: A ten-week pivotal clinical trial at TriCore Reference Laboratories in New Mexico during July and August 2015 tested APAS against a panel of microbiologists. Culture plates from 5,500 patients were processed by APAS and simultaneously assessed by a panel of independent qualified microbiologists. The results showed that APAS achieved over […]
LBT Innovations (ASX:LBT) has published the details of its extensive study into the accuracy of its Automated Plate Assessment System (APAS). Results from the study were released in a poster presentation at the Australian Society for Microbiology annual meeting in Melbourne this week. The poster confirms the headline result that, comparing the screening of hundreds of clinical samples by APAS […]
Lusia Guthrie was interviewed by Amanda Vanstone about our collaboration on the ABC’s Counterpoint program. The ex Foreign Minster was particularly pleased that the technology was developed in South Australia. The audio is available here.
From the LBT Innovations ASX release: 15 April 2013, Adelaide: Medical technology company LBT Innovations Limited (ASX: LBT) has signed an agreement with the Switzerland-based laboratory instrumentation company, Hettich AG Switzerland, to finalise a partnership to complete the development and commercialisation of LBT’s Automated Plate Assessment System (APAS®). The APAS system is built upon technology […]
ACVT has been awarded a 3 year ARC Linkage Grant valued at $510,000. The industry partner on the grant is LBT Innovations, an SA based biomedical company. The CIs on the project are Prof. Anton van den Hengel, Dr Chunhua Shen and Dr Qinfeng Shi. Classification is a fundamental data analysis technology and is applied […]